It is a fusion protein of a humanized monoclonal antibody (tucotuzumab) and an interleukin-2 (celmoleukin).
It is an amalgamation of a humanized monoclonal antibody (tucotuzumab) and interleukin-2 (celmoleukin), both fused into a single protein.